By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Arrayit today announced it is spinning out its majority-owned subsidiary Arrayit Diagnostics, which it expects to be listed on the Over-the-Counter Bulletin Board.

Arrayit will distribute its 78.18 percent interest in Arrayit Diagnostics as a stock dividend to its existing shareholders. The dividend distribution date and further details will be announced in the first quarter of 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.